Jump to Navigation
MDA | Muscular Dystrophy Association
  • About MDA
  • Advocacy
  • Publications
  • Media
Give Now.
Give online Give by mail Give by phone

Main menu

  • Home
  • Learn About Muscle Diseases
  • Help Through Services
  • Hope Through Research
  • Ways to Help MDA

Search form

Research News

[title]
ALS TDI Webinar Discusses Current Research
April 21, 2011
The state of the science in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease), current lines of research, efforts to establish a TDP43 research mouse colony, and a primer on protein-based
[title]
AAN Research Briefs on DM, DMD, LGMD, MG, MMD, SMA
April 20, 2011
Below are brief reports and links to more information about neuromuscular disease research presented at the 63rd annual meeting of the American Academy of Neurology (AAN), held in Honolulu April 9-16
[title]
ALS Research Briefs from 2011 AAN Meeting
April 15, 2011
Neuralstem's trial of spinal cord injections of stem cells is on track The first nine participants in a phase 1 (safety and feasibility) trial of neural stem cell transplantation in amyotrophic
[title]
MDA Surveying Families about ‘Cost of Illness’
April 13, 2011
Most people affected by neuromuscular disease know all too well that their condition is costly. MDA wants to find out just how costly — and then translate those figures into terms that will speak
[title]
Research Briefs: CMT, IBM, LGMD, MTM/CNM, Pompe disease
March 31, 2011
Charcot-Marie-Tooth disease A two-year, large-scale trial of ascorbic acid (vitamin C) in people with type 1A Charcot-Marie-Tooth disease (CMT1A) conducted in Italy and the United Kingdom has found
[title]
Phase 3 Trial of Dexpramipexole Launched in ALS
March 30, 2011
Update 8/31/11: Enrollment screening for this study has closed to new prospective participants. "EMPOWER," a large-scale, global phase 3 clinical trial of a molecule called dexpramipexole in ALS (
[title]
Research Briefs: DMD Exon Skipping
March 29, 2011
sClinical trials that use compounds called antisense oligonucleotides to cause skipping of exon 51 of the dystrophin gene in individuals with Duchenne muscular dystrophy (DMD) are moving forward in
[title]
MDA Awards Grant to Glialogix to Test Potential ALS Treatment
March 24, 2011
MDA is funding research into a potential treatment for amyotrophic lateral sclerosis (ALS) that inhibits excessive glutamate signaling in the brain and spinal cord. The grant of $268,000 to Larkspur
[title]
DMD/BMD Drug Screen in Zebrafish Finds Three Candidates
March 24, 2011
Three small molecules that normalize muscle structure and function and improve survival in dystrophin-deficient zebrafish have been identified by scientists at Children's Hospital Boston, Harvard
[title]
ALS Research Briefs
March 23, 2011
TDP43 has unexpectedly extensive role Scientists have found that the protein TDP43 normally influences the synthesis of more than 1,500 other proteins, including itself. Mutations in the gene for
[title]
MDA Awards Grant to Test Heat Shock Protein in ALS Mice
March 21, 2011
UPDATE (April 9, 2012): MDA and ALS Biopharma agreed to terminate this project in April 2012, when ALS Biopharma determined that it was unable to manufacture its HSP70-based compound in a pure enough
[title]
MDA Conference Brings Together Researchers, Clinicians, Industry
March 18, 2011
Moving therapeutic strategies from the laboratory to clinical trials and ultimately to the market as treatments was the theme of the MDA National Scientific Conference held March 13-16, 2011, in Las
[title]
'Antisense' Ameliorates SMA Symptoms in Mice
March 15, 2011
A team of research scientists has found that mice with a disease resembling a severe form of spinal muscular atrophy (SMA) that were treated with a gene-modifying molecule produced more of a needed
[title]
MDA Awards Grant to Test Potential MG Treatment
March 14, 2011
MDA’s translational research program has announced it is funding research into a potential treatment for the autoimmune disorder myasthenia gravis (MG). The grant of $530,480 to University of
[title]
IL10 Protein May Influence DMD Severity
March 09, 2011
A team of researchers at the David Geffen School of Medicine at the University of California-Los Angeles (UCLA) has demonstrated that the naturally occurring protein interleukin 10 (IL10) may help
[title]
Reactivated Virus May Contribute to ALS
March 07, 2011
New research suggests that the DNA of a normally dormant virus may be playing a role in causing amyotrophic lateral sclerosis (ALS). If the findings are confirmed, they could ultimately have
[title]
ALS Research Briefs
March 03, 2011
Loss of TDP43's normal function could be ALS contributor New mouse studies suggest that loss of the normal function of the TDP43 protein, and not just an abnormal "toxic gain of function" of this
[title]
MDA Awards $2 Million to ALS TDI
March 02, 2011
MDA has awarded $2 million to the ALS Therapy Development Institute (ALS TDI) in Cambridge, Mass., to help scientists complete the preclinical testing of four promising new compounds in ALS TDI's
[title]
Research Briefs: CMS, DMD, LGMD, Pompe, Stem Cells
February 25, 2011
Congenital myasthenic syndromes A multinational team of scientists has identified mutations in the gene for glutamine-fructose-6-phosphate transaminase 1 (GFPT1) as responsible for some forms of a
[title]
Research Briefs: CMT, CMS, DMD/BMD, FA, Pompe disease, SBMA
February 10, 2011
Charcot-Marie-Tooth disease Researchers supported in part by MDA have developed flow charts to guide genetic testing for the various subtypes of Charcot-Marie-Tooth disease (CMT), streamlining the
[title]
ALS Therapy Development Institute: Looking Ahead to 2011
February 10, 2011
New space for research, new mouse models of ALS and new technology to screen therapeutic agents all will play a role in 2011 at the ALS Therapy Development Institute (ALS TDI), said Steve Perrin, ALS
[title]
UCLA Researcher Receives MDA Grant to Develop DMD Drug
February 09, 2011
A new MDA translational research grant for $476,465 over three years will allow Carmen Bertoni at the University of California, Los Angeles (UCLA) to develop RTC13, an experimental compound designed
[title]
Eight New Grants Bolster MDA's Battle Against ALS
February 04, 2011
MDA has awarded eight new grants totaling nearly $2.5 million to fund research projects focused on uncovering the causes of, and developing therapies for, ALS. The effective start date for the grants
[title]
MDA Awards $13.5 Million in Research Grants
February 04, 2011
The Muscular Dystrophy Association has awarded 44 grants totaling $13.5 million to support research efforts aimed at advancing understanding of disease processes and uncovering new strategies for
[title]
Isis Hosts Webinar for SOD1-Rx Trial
February 02, 2011
Isis Pharmaceuticals hosted an interactive webinar Wednesday, March 2, 2011, at 12 noon Eastern Standard Time, to help prospective participants understand its MDA-supported, phase 1 study of ISIS-

Pages

  • « first
  • ‹ previous
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • next ›
  • last »
View All News

Research

  • Research News
  • Active Research Grants
  • Research Grants Programs
  • MDA Translational Research Program
    • Clinical Research Training Grant (CRTG)
    • Funded Projects
    • MDA Venture Philanthropy
  • Opportunities for Researchers
  • Annual Conference Series
  • Grants at a Glance — Winter 2013
  • MDA Research Contact
  • Helpful Links
  • Clinical Trials and Studies
  • Clinical Research Network Grant
  • Newborn Screening for Neuromuscular Diseases
  • MyoBlast Research Newsletter
    • Volume 1, Issue 1, October 2011
    • Volume 2, Issue 1, February 2012
MDA in Your Community


Quick Links

  • Tell Us About Your MDA Clinic
  • Become an MDA Advocate
  • Be a Summer Camp Volunteer
  • Sign Up for MDA News Updates
  • MDA's Muscle Shop

Give Now.

Ways To Help

  • Advocacy
  • Become a Volunteer
  • Donor Login
  • Legacy Gifts
  • MDA Programs
  • Matching Gifts

About MDA

  • Art Collection
  • Contact MDA
  • Become a Volunteer
  • Careers
  • FAQ
  • Media
  • What is MDA?

MDA.org

  • Find Support
  • Get Involved
  • Publications
  • Site Map
  • Muscle Shop

Connect with MDA

  • Facebook Twitter YouTube  

Muscular Dystrophy Association — USA
National Headquarters
3300 E. Sunrise Drive
Tucson, AZ 85718
(800) 572-1717

Privacy Policy | Terms of Use

©2013, Muscular Dystrophy Association Inc. All rights reserved.
 

Advertise